Skip to main content
. 2015 May 4;33(18):2112–2118. doi: 10.1200/JCO.2014.59.7203

Fig 1.

Fig 1.

Survival analysis. Progression-free survival (PFS) analysis (A) in patients with Burkitt's lymphoma at high risk (Berlin-Frankfurt-Munster high-risk group R4) according to morphologic bone marrow (BM) status at diagnosis and (B) according to minimal disseminated disease (MDD) status in BM at diagnosis. Data adapted.30